• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌萎缩侧索硬化症患者的护理轨迹及对呼吸管理建议的依从性:法国一所三级大学中心的十年队列研究

Care trajectories and adherence to respiratory management recommendations in persons living with amyotrophic lateral sclerosis: a ten-year cohort study in a French tertiary university centre.

作者信息

Tankéré Pierre, Cascarano Estelle, Saint Raymond Christel, Mallaret Martial, Toribio Ruiz Cristina, Herquelot Eléonore, Denis Helene, Cals Maurette Mallory, Tamisier Renaud, Pépin Jean Louis

机构信息

University Grenoble Alpes, Grenoble, France.

Center for Sleep Medicine, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France.

出版信息

Amyotroph Lateral Scler Frontotemporal Degener. 2025 May;26(3-4):259-267. doi: 10.1080/21678421.2024.2447911. Epub 2025 Jan 3.

DOI:10.1080/21678421.2024.2447911
PMID:39749674
Abstract

: This study determined real-life care trajectories before and after initiation of noninvasive ventilation (NIV) in patients with amyotrophic lateral sclerosis (ALS). Caregiver adherence to respiratory management recommendations and the associated survival rate of people with ALS were also assessed. : Data were obtained from a tertiary center prospective ALS database that included 10 years of follow-up data for people with ALS. Results are presented numerically and with graphical time sequence analysis through K clustering (TAK) representation. Kaplan Meier and Cox models were used to determine survival and associated prognostic factors. 109 patients with ALS patients were included; median [interquartile range] follow-up was 25.0 months [15.3-43.3]. During study timeframe patients had a median of 4.0 [2.0-6.0] clinical visits; death occurred in 54.1%. Median time between clinical visits was 3.9 [2.8-6.5] months, between arterial blood gases was 4.3 months [3.0-6.6], between spirometry testing was 5.8 months [4.1-8.2], and between nocturnal oximetry was 4.4 months [3.0-7.8]. Visualization of care trajectories TAK show marked heterogeneity in survival, time to NIV initiation, and time from NIV initiation to death. Mortality was correlated with NIV initiation and arterial carbon dioxide pressure increase. : The current framework in ALS guidelines should be adapted to the ALS disease stage and individual patient characteristics. Understanding how subgroups of patients with ALS use healthcare services over time could help to highlight fragility areas and priorities in the allocation of care resources and implementation of best practices.

摘要

本研究确定了肌萎缩侧索硬化症(ALS)患者在开始无创通气(NIV)之前和之后的实际护理轨迹。还评估了护理人员对呼吸管理建议的依从性以及ALS患者的相关生存率。:数据来自一个三级中心前瞻性ALS数据库,该数据库包含了ALS患者10年的随访数据。结果以数字形式呈现,并通过K聚类(TAK)表示进行图形时间序列分析。使用Kaplan Meier和Cox模型来确定生存率和相关的预后因素。纳入了109例ALS患者;中位[四分位间距]随访时间为25.0个月[15.3 - 43.3]。在研究期间,患者的临床就诊中位数为4.0[2.0 - 6.0]次;54.1%的患者死亡。临床就诊之间的中位时间为3.9[2.8 - 6.5]个月,动脉血气检查之间为4.3个月[3.0 - 6.6],肺活量测定检查之间为5.8个月[4.1 - 8.2],夜间血氧饱和度测定之间为4.4个月[3.0 - 7.8]。护理轨迹TAK的可视化显示,在生存率、开始NIV的时间以及从开始NIV到死亡的时间方面存在明显的异质性。死亡率与开始NIV和动脉二氧化碳压力升高相关。:ALS指南中的当前框架应根据ALS疾病阶段和个体患者特征进行调整。了解ALS患者亚组如何随时间使用医疗保健服务,有助于突出护理资源分配和最佳实践实施中的脆弱领域和重点。

相似文献

1
Care trajectories and adherence to respiratory management recommendations in persons living with amyotrophic lateral sclerosis: a ten-year cohort study in a French tertiary university centre.肌萎缩侧索硬化症患者的护理轨迹及对呼吸管理建议的依从性:法国一所三级大学中心的十年队列研究
Amyotroph Lateral Scler Frontotemporal Degener. 2025 May;26(3-4):259-267. doi: 10.1080/21678421.2024.2447911. Epub 2025 Jan 3.
2
Initiation of non-invasive ventilation in amyotrophic lateral sclerosis and clinical practice guidelines: Single-centre, retrospective, descriptive study in a national reference centre.肌萎缩侧索硬化症无创通气的启动及临床实践指南:在一家国家参考中心进行的单中心、回顾性、描述性研究。
Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):46-52. doi: 10.1080/21678421.2016.1236817. Epub 2016 Dec 15.
3
DiPALS: Diaphragm Pacing in patients with Amyotrophic Lateral Sclerosis - a randomised controlled trial.DiPALS:肌萎缩侧索硬化症患者的膈肌起搏——一项随机对照试验。
Health Technol Assess. 2016 Jun;20(45):1-186. doi: 10.3310/hta20450.
4
Prognostic value of efficiently correcting nocturnal desaturations after one month of non-invasive ventilation in amyotrophic lateral sclerosis: a retrospective monocentre observational cohort study.在肌萎缩侧索硬化症患者接受无创通气一个月后有效纠正夜间低氧血症的预后价值:一项回顾性单中心观察队列研究。
Amyotroph Lateral Scler Frontotemporal Degener. 2013 Sep;14(5-6):373-9. doi: 10.3109/21678421.2013.776086. Epub 2013 Mar 26.
5
Initiation of noninvasive ventilation in patients with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者的无创通气启动。
Muscle Nerve. 2024 Nov;70(5):1099-1103. doi: 10.1002/mus.28250. Epub 2024 Sep 7.
6
[Proposals from a French expert panel for respiratory care in ALS patients].[法国专家小组关于肌萎缩侧索硬化症患者呼吸护理的建议]
Rev Mal Respir. 2024 Oct;41(8):620-637. doi: 10.1016/j.rmr.2024.06.006. Epub 2024 Jul 16.
7
Tolerance of Volume Control Noninvasive Ventilation in Subjects With Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症患者对容量控制无创通气的耐受性
Respir Care. 2015 Dec;60(12):1765-71. doi: 10.4187/respcare.04172. Epub 2015 Sep 29.
8
Non-invasive ventilation effectiveness and the effect of ventilatory mode on survival in ALS patients.非侵入性通气治疗的效果以及通气模式对 ALS 患者生存的影响。
Amyotroph Lateral Scler Frontotemporal Degener. 2014 Mar;15(1-2):55-61. doi: 10.3109/21678421.2013.855790. Epub 2013 Nov 25.
9
Dyspnea in amyotrophic lateral sclerosis: The Dyspnea-ALS-Scale (DALS-15) essentially contributes to the diagnosis of respiratory impairment.肌萎缩侧索硬化症中的呼吸困难:呼吸困难-肌萎缩侧索硬化症量表(DALS-15)对呼吸功能损害的诊断具有重要意义。
Respir Med. 2019 Jul-Aug;154:116-121. doi: 10.1016/j.rmed.2019.06.014. Epub 2019 Jun 19.
10
Alveolar Ventilation-Targeted Versus Spontaneous/Timed Mode for Home Noninvasive Ventilation in Amyotrophic Lateral Sclerosis.肺泡通气-目标与自主/定时模式在家中肌萎缩侧索硬化症的无创通气。
Respir Care. 2022 Sep;67(9):1109-1120. doi: 10.4187/respcare.09580. Epub 2022 Mar 4.

引用本文的文献

1
Pathophysiology, Clinical Heterogeneity, and Therapeutic Advances in Amyotrophic Lateral Sclerosis: A Comprehensive Review of Molecular Mechanisms, Diagnostic Challenges, and Multidisciplinary Management Strategies.肌萎缩侧索硬化症的病理生理学、临床异质性及治疗进展:分子机制、诊断挑战与多学科管理策略的全面综述
Life (Basel). 2025 Apr 14;15(4):647. doi: 10.3390/life15040647.